NDC 50242-103

POLIVY

Polatuzumab Vedotin

POLIVY is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Polatuzumab Vedotin.

• Product ID: 50242-103_4acd1567-4ce4-4cbd-a602-043acc8396ef
• NDC: 50242-103
• Product Type: Human Prescription Drug
• Proprietary Name: POLIVY
• Generic Name: Polatuzumab Vedotin
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2019-06-10
• Marketing Category: BLA / BLA
• Application Number: BLA761121
• Labeler Name: Genentech, Inc.
• Substance Name: POLATUZUMAB VEDOTIN
• Active Ingredient Strength: 30 mg/1.88mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 50242-103-01

1 VIAL in 1 CARTON (50242-103-01) > 6 mL in 1 VIAL

• Marketing Start Date: 2020-09-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "POLIVY" or generic name "Polatuzumab Vedotin"

NDC	Brand Name	Generic Name
50242-103	POLIVY	polatuzumab vedotin
50242-105	POLIVY	polatuzumab vedotin